Could a fourth drug beat a tough infection in HIV patients?
NCT ID NCT07585461
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study looks at whether adding a fluoroquinolone antibiotic to the usual three-drug treatment helps people with HIV who have a serious infection called disseminated MAC. About 124 adults will be randomly assigned to get either the standard triple therapy or a four-drug regimen for the first 8 weeks. The main goal is to see if symptoms improve faster by day 28, while also checking safety and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPPORTUNISTIC INFECTIONS, HIV RELATED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.